title: Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.
authors.affiliation: Department of Blood and Marrow Transplantation, University of Texas-MD Anderson Cancer Center, Houston 77030, USA. rchampli@mdacc.tmc.edu
authors.forename: R
authors.initials: R
authors.lastname: Champlin
authors.forename: I
authors.initials: I
authors.lastname: Khouri
authors.forename: A
authors.initials: A
authors.lastname: Shimoni
authors.forename: J
authors.initials: J
authors.lastname: Gajewski
authors.forename: S
authors.initials: S
authors.lastname: Kornblau
authors.forename: J
authors.initials: J
authors.lastname: Molldrem
authors.forename: N
authors.initials: N
authors.lastname: Ueno
authors.forename: S
authors.initials: S
authors.lastname: Giralt
authors.forename: P
authors.initials: P
authors.lastname: Anderlini
mesh_terms: D016026:Bone Marrow Transplantation / Q000379:methods*; D006086:Graft vs Host Disease; D020544:Graft vs Leukemia Effect; D020350:Graft vs Tumor Effect; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008223:Lymphoma / Q000628:therapy*; D013601:T-Lymphocytes / Q000637:transplantation; D014184:Transplantation, Homologous